Allogene Therapeutics, Inc. · NASDAQ:ALLO
Beneski Benjamin Machinas sold 2,867 Allogene Therapeutics, Inc. shares (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Beneski Benjamin Machinas (SVP, Chief Technical Officer) sold 2,867 Allogene Therapeutics, Inc. shares at US$2.50 for US$7,168, leaving 195,338 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 2,867 shares
- Price
- US$2.50
- Value
- US$7,168
- Holding after
- 195,338 shares
- Trading plan
- No
- Role
- SVP, Chief Technical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Sale | 2,867 | US$2.50 | 195,338 | Direct |
Source
Related
- Allogene Therapeutics, Inc.
- Beneski Benjamin Machinas
- Allogene Therapeutics, Inc. shareholders
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026